Folgen
Federico Rotolo
Federico Rotolo
Bestätigte E-Mail-Adresse bei sanofi.com - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Tumor mutation burden as a biomarker in resected non–small-cell lung cancer
S Devarakonda, F Rotolo, MS Tsao, I Lanc, E Brambilla, A Masood, ...
Journal of Clinical Oncology 36 (30), 2995, 2018
2302018
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label …
M Bagot, P Porcu, A Marie-Cardine, M Battistella, BM William, M Vermeer, ...
The Lancet Oncology 20 (8), 1160-1170, 2019
1282019
parfm: Parametric Frailty Models in R
M Munda, F Rotolo, C Legrand
Journal of Statistical Software 51 (11), 2012
1272012
Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models
N Ternès, F Rotolo, S Michiels
Statistics in Medicine, 2016
882016
Circular statistics
U Lund, C Agostinelli, H Arai, A Gagliardi, EG Portugues, D Giunchi, ...
R package version 4, 93, 2017
64*2017
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial
RJ Kreitman, C Dearden, PL Zinzani, J Delgado, T Robak, PD le Coutre, ...
Journal of hematology & oncology 14, 1-11, 2021
572021
Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice
S Michiels, N Ternès, F Rotolo
Annals of Oncology 27 (12), 2160-2167, 2016
492016
Surrogate end points for overall survival in loco-regionally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis
F Rotolo, JP Pignon, J Bourhis, S Marguet, J Leclercq, W Tong Ng, J Ma, ...
JNCI: Journal of the National Cancer Institute 109 (4), djw239, 2017
472017
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort
M Kandel, C Allayous, S Dalle, L Mortier, S Dalac, C Dutriaux, MT Leccia, ...
European Journal of Cancer 105, 33-40, 2018
442018
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
B Lueza, F Rotolo, J Bonastre, JP Pignon, S Michiels
BMC medical research methodology 16, 1-14, 2016
442016
Combination of monalizumab and cetuximab in recurrent or metastatic head and neck cancer patients previously treated with platinum-based chemotherapy and PD-(L) 1 inhibitors.
RB Cohen, JR Bauman, S Salas, AD Colevas, C Even, D Cupissol, ...
Journal of Clinical Oncology 38 (15_suppl), 6516-6516, 2020
392020
Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces
N Ternes, F Rotolo, G Heinze, S Michiels
Biometrical Journal 59 (4), 685-701, 2017
392017
surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials
F Rotolo, X Paoletti, S Michiels
Computer methods and programs in biomedicine 155, 189-198, 2018
342018
Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients
A Stoclin, F Rotolo, Y Hicheri, M Mons, E Chachaty, B Gachot, JP Pignon, ...
Supportive Care in Cancer 28, 193-200, 2020
322020
A simulation procedure based on copulas to generate clustered multi-state survival data
F Rotolo, C Legrand, I Van Keilegom
Computer Methods and Programs in Biomedicine 109 (3), 305-312, 2013
312013
Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach
F Rotolo, A Dunant, T Le Chevalier, JP Pignon, R Arriagada
Annals of Oncology 25 (11), 2162-2166, 2014
30*2014
French intensive care society, international congress-réanimation 2016
E Jaillette, C Girault, G Brunin, F Zerimech, A Chiche, ...
Annals of Intensive Care 6 (Suppl 1), 50-50, 2016
212016
biospear: an R package for biomarker selection in penalized Cox regression
N Ternès, F Rotolo, S Michiels
Bioinformatics 34 (1), 112-113, 2018
182018
A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses
F Rotolo, X Paoletti, T Burzykowski, M Buyse, S Michiels
Statistical Methods in Medical Research 28 (1), 170-183, 2019
172019
Predictor of effectiveness of treatment intensification on overall survival in head and neck cancer (HNC)
K Zakeri, F Rotolo, B Lacas, LK Vitzthum, QTX Le, V Gregoire, ...
Annals of Oncology 29, viii375-viii376, 2018
16*2018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20